CUSIP | Jotup

Motus GI Announces 1-for-15 Reverse Stock Split

Retrieved on:

Wednesday, November 1, 2023

Transfer, Exercise, CUSIP, Security (finance)

FORT LAUDERDALE, Fla., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company focused on improving endoscopic outcomes and experiences, announced today that it will effect a 1-for-15 reverse stock split of its outstanding common stock.

Key Points:

FORT LAUDERDALE, Fla., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company focused on improving endoscopic outcomes and experiences, announced today that it will effect a 1-for-15 reverse stock split of its outstanding common stock.
As a result of the reverse stock split, every fifteen pre-split shares of common stock outstanding will become one share of common stock.
The reverse stock split will not change the authorized number of shares of the Company’s common stock.
The reverse stock split will affect all stockholders uniformly and will not alter any stockholder’s percentage interest in the Company’s equity, except to the extent that the reverse stock split results in some stockholders owning a fractional share.

Jeffs’ Brands Announces 1-for-7 Reverse Share Split

Retrieved on:

Tuesday, October 31, 2023

CUSIP, TEL, Exercise, Amazon Marketplace, Shareholder, Security (finance)

TEL AVIV, Israel, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Jeffs’ Brands Lt. (Nasdaq: JFBR) (“Company” or “Jeffs’ Brands”) a data-driven e-commerce company operating on the Amazon Marketplace, announced today that it will conduct a reverse share split of its issued and outstanding ordinary shares, no par value, at a ratio of 1-for-7. The Company’s Ordinary Shares will begin trading on the Nasdaq Capital Market on a post-split basis at the market open on November 3, 2023, under the Company’s existing trading symbol “JFBR”. The trading symbol “JFBRW” and CUSIP number for the Company’s public warrants will remain unchanged following the reverse share split.

Key Points:

Following the reverse share split, the Company will have approximately 1,188,805 Ordinary Shares issued and outstanding.
TEL AVIV, Israel, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Jeffs’ Brands Lt. (Nasdaq: JFBR) (“Company” or “Jeffs’ Brands”) a data-driven e-commerce company operating on the Amazon Marketplace, announced today that it will conduct a reverse share split of its issued and outstanding ordinary shares, no par value, at a ratio of 1-for-7.
The trading symbol “JFBRW” and CUSIP number for the Company’s public warrants will remain unchanged following the reverse share split.
The reverse share split was approved by the Company’s shareholders at the Company’s Annual Meeting of Shareholders held on September 5, 2023 to be effected in the board of director’s discretion within approved parameters.

PaxMedica Announces 1-for-17 Reverse Stock Split

Retrieved on:

Monday, October 30, 2023

IBN, ASD, APT, Autism spectrum, CUSIP, Security (finance)

PaxMedica’s common stock will continue to trade under the existing trading symbol “PXMD.” The new CUSIP number for the common stock following the reverse stock split is 70424C 203.

Key Points:

PaxMedica’s common stock will continue to trade under the existing trading symbol “PXMD.” The new CUSIP number for the common stock following the reverse stock split is 70424C 203.
As a result of the reverse stock split, each 17 pre-split shares of common stock outstanding were automatically combined and converted into one issued and outstanding share of common stock.
No fractional shares of common stock were issued to any stockholders in connection with the reverse stock split.
Stockholders of record will receive information regarding their share ownership following the reverse stock split from the Company’s transfer agent, Computershare Trust Corporation, N.A.

Catalyst Biosciences Announces Completion of Business Combination With Beijing Continent Pharmaceuticals and Implementation of Name Change and Reverse Stock Split

Retrieved on:

Monday, October 30, 2023

Trial of the century, Health, Catalysis, CUSIP, Proxy, Inflammation, Research, Therapy, Annual report, Patient, Failure, SAN, Cryptocurrency, Security (finance), Ocean gyre

SAN DIEGO, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (Nasdaq: CBIO) (“Catalyst”) today announced completion of the business combination with GNI Group Ltd. and related entities. Catalyst received stockholder approval for all proposals necessary to complete the business combination at a special meeting of stockholders held on August 29, 2023. Catalyst effected a name change and a reverse stock split of Catalyst’s common stock immediately prior to the closing of the business combination. The combined company will operate under the name “Gyre Therapeutics, Inc.” (“Gyre”). As a result of the business combination, Beijing Continent Pharmaceuticals Co., Ltd. became a majority-owned subsidiary of Gyre.

Key Points:

Catalyst effected a name change and a reverse stock split of Catalyst’s common stock immediately prior to the closing of the business combination.
As a result of the business combination, Beijing Continent Pharmaceuticals Co., Ltd. became a majority-owned subsidiary of Gyre.
In the reverse stock split, every 15 shares of Catalyst common stock outstanding was combined and reclassified into one share of Gyre common stock.
The new CUSIP number for Gyre common stock following the reverse stock split, business combination and other attendant transactions is 403783 103.

Novo Integrated Sciences Announces Reverse Stock Split

Retrieved on:

Monday, November 6, 2023

General Health, Health, Science, Other Science, Health Technology, Reverse stock split, CUSIP, Aphria (company), American University of Integrative Sciences, Novo, Effective date, Auction

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today announced that the Company will undertake a reverse stock split of its common stock at a ratio of 1-for-10 (the "Reverse Stock Split").

Key Points:

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today announced that the Company will undertake a reverse stock split of its common stock at a ratio of 1-for-10 (the "Reverse Stock Split").
The Reverse Stock Split is expected to become effective immediately after the close of trading on the Nasdaq Capital Market ("Nasdaq") on November 6, 2023 (the "Effective Date") and the Company’s common stock is expected to begin trading on Nasdaq on a Reverse Stock Split-adjusted basis on November 7, 2023, under the new CUSIP number, 67011T300.
We believe that by promptly addressing the uncertainty regarding our listing we will be better positioned to maximize value for our shareholders.”
Stockholder approval for the Reverse Stock Split was obtained at the Company's annual meeting of stockholders on September 29, 2023.
After careful consideration in light of current market conditions, the Company's Board of Directors approved the Reverse Stock Split ratio of 1-for-10.

Cazoo Launches Exchange Offer Relating to Existing Convertible Notes

Retrieved on:

Friday, November 3, 2023

The obligation of the Company to complete the Exchange Offer is subject to certain conditions, including the receipt of Convertible Notes validly tendered (and not validly withdrawn) prior to the Expiration Deadline representing not less than 100% of the aggregate principal amount of Convertible Notes outstanding (the “Minimum Exchange Condition”).

Key Points:

The obligation of the Company to complete the Exchange Offer is subject to certain conditions, including the receipt of Convertible Notes validly tendered (and not validly withdrawn) prior to the Expiration Deadline representing not less than 100% of the aggregate principal amount of Convertible Notes outstanding (the “Minimum Exchange Condition”).
If the Exchange Offer is not completed due to failure to satisfy the Minimum Exchange Condition, the Company will implement the Exchange Offer through an English restructuring plan or scheme of arrangement rather than through this Exchange Offer (a “Scheme Transaction”).
As a result, if holders of the Convertible Notes do not tender their Convertible Notes in the Exchange Offer or if the Exchange Offer is not completed due to the failure to satisfy the Minimum Exchange Condition, holders of Convertible Notes, subject to the sanction of the English court, will likely still be exchanged into the Offered Securities pursuant to a Scheme Transaction.
Requests for the Offering Memorandum and other documents relating to the Exchange Offer may be directed to U.S. Bank Trust Company, National Association, the exchange agent and information agent for the Exchange Offer, toll free at (800) 934-6802.

Agilysys Announces Mandatory Conversion Date for Series A Convertible Preferred Stock

Retrieved on:

Friday, November 3, 2023

Professional Services, Technology, Other Travel, Lodging, Software, Finance, Travel, Certificate, ISIN, CUSIP, Security (finance), Agilysys

Agilysys, Inc. (Nasdaq: AGYS) announced today that it has delivered a notice of mandatory conversion to the holders of its 5.25% Series A convertible preferred stock.

Key Points:

Agilysys, Inc. (Nasdaq: AGYS) announced today that it has delivered a notice of mandatory conversion to the holders of its 5.25% Series A convertible preferred stock.
This notice informs convertible preferred stock shareholders that Agilysys has exercised its right to mandate that all outstanding shares of convertible preferred stock convert to shares of Agilysys common stock, as detailed in the Certificate of Designation of 5.25% Series A Convertible Preferred Shares of Agilysys, Inc.
As set forth in the Certificate of Designation, holders of convertible preferred stock have the option to convert those shares to Agilysys common stock before the mandatory conversion date if done before the close of business November 21, 2023, the second business day immediately preceding the mandatory conversion date.
Any shares of convertible preferred stock not converted to common shares by the mandatory conversion date will no longer be deemed outstanding and all holder rights for those shares, including dividend accruals, will terminate.

Dogness (International) Corporation Announces 1-for-20 Class A Common Share Consolidation

Retrieved on:

Monday, November 6, 2023

Articles of association, OEM, International, Dogs of the Dow, CUSIP, Class, Share (finance), Cryptocurrency, Security (finance)

This amendment will result in a change to the Company's authorized shares and par value and effect a share consolidation of the Company's issued and outstanding Class A common shares ("Class A Shares") at the ratio of 1-for-20 with the marketplace effective date of November 7, 2023.

Key Points:

This amendment will result in a change to the Company's authorized shares and par value and effect a share consolidation of the Company's issued and outstanding Class A common shares ("Class A Shares") at the ratio of 1-for-20 with the marketplace effective date of November 7, 2023.
As a result of the share consolidation, each twenty Class A Shares outstanding will automatically combine and convert to one issued and outstanding common share without any action on the part of the shareholders.
The share consolidation will reduce the number of Class A Shares outstanding from 31,055,259 to approximately 1,552,763 (subject to the redemption of the fractional shares).
Both before and after the Share Consolidation, the outstanding number of Class B Shares is 9,069,000 shares.

Broadway Financial Corporation Announces Terms of Reverse Stock Split

Retrieved on:

Tuesday, October 31, 2023

Banking, Professional Services, Finance, Security (finance), CUSIP, Securities and Exchange Commission (Nigeria), Reverse, Broadway, Broadway Federal Bank, Stock split, Class, Failure, National Association, Cryptocurrency

Broadway Financial Corporation (“Broadway,” “we,” or the “Company”) (Nasdaq Capital Market: BYFC), parent company of City First Bank, National Association, announced today the terms of the Company’s previously disclosed reverse stock split (the “Reverse Split”).

Key Points:

Broadway Financial Corporation (“Broadway,” “we,” or the “Company”) (Nasdaq Capital Market: BYFC), parent company of City First Bank, National Association, announced today the terms of the Company’s previously disclosed reverse stock split (the “Reverse Split”).
The Reverse Split will be effective at 12:01 a.m. Eastern Time on November 1, 2023 for all outstanding shares of Broadway’s three classes of common stock: Class A common stock, Class B common stock, and Class C common stock.
The Class B common stock and Class C common stock are not registered for trading and will not be registered after the effective time for the Reverse Split.
Immediately following the Reverse Split there will be approximately 9,019,187 shares of common stock outstanding, comprised of 5,921,046 shares of Class A common stock, 1,425,577 shares of Class B common stock and 1,672,564 shares of Class C common stock.

Alzamend Neuro Announces Reverse Stock Split

Retrieved on:

Monday, October 30, 2023

Biotechnology, General Health, Neurology, Health, Pharmaceutical, Post-traumatic stress disorder, Computershare, CUSIP, Bipolar disorder, Exercise, Common stock, Common, Security (finance)

The reverse stock split affects all issued and outstanding shares of the Company’s Common Stock, as well as the number of shares of Common Stock available for issuance under the Company’s equity incentive plans.

Key Points:

The reverse stock split affects all issued and outstanding shares of the Company’s Common Stock, as well as the number of shares of Common Stock available for issuance under the Company’s equity incentive plans.
In addition, the reverse stock split reduces the number of shares of Common Stock issuable upon the exercise of stock options or warrants outstanding immediately prior to the reverse split.
The par value of the Company’s Common Stock will remain unchanged at $0.0001 per share after the reverse stock split.
The reverse stock split affects all stockholders uniformly and will not alter any stockholder’s percentage interest in the Company’s equity, except to the extent that the reverse stock split results in some stockholders owning a fractional share.